Inotiv (NOTVQ) Cash from Financing Activities (2010 - 2026)
Inotiv's (NOTVQ) quarterly Cash from Financing Activities came in at $5.9 million in Q1 2026, up 1031.33% YoY from $520273.0 in Q1 2025, and up 283.2% on a QoQ basis from $1.5 million in Q4 2025.
Inotiv (NOTVQ) Cash from Financing Activities (2010 - 2026) Analysis & Trends
Inotiv (NOTVQ) has 17 years of Cash from Financing Activities data on file, last reported at $5.9 million in Q1 2026.
- Quarterly Cash from Financing Activities rose 1031.33% year-over-year to $5.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $5.6 million (down 85.66% YoY) and the FY2025 annual result came in at $23.7 million, up 144.97% from the prior year.
- Cash from Financing Activities advanced to $5.9 million in Q1 2026, from $1.5 million in the prior quarter.
- In the past five years, Cash from Financing Activities ranged from a high of $71.1 million in Q1 2022 to a low of -$3.4 million in Q2 2025.
- A 5-year average of $8.3 million and a median of -$310000.0 in 2023 frame the typical range for Cash from Financing Activities.
- Annual changes were most pronounced in 2022 — Cash from Financing Activities soared 8066.93% — and 2025, when it slumped 328.93%.
- Tracing NOTVQ's Cash from Financing Activities over 5 years: stood at $18.4 million in 2022, then plunged by 115.89% to -$2.9 million in 2023, then jumped by 994.39% to $26.1 million in 2024, then sank by 94.12% to $1.5 million in 2025, then surged by 283.2% to $5.9 million in 2026.
- The last three Cash from Financing Activities figures came in at $5.9 million (Q1 2026), $1.5 million (Q4 2025), and $1.6 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 234.15 Bn | 230.09 Bn | 8.34 Bn | -1.57 Bn |
| 2 | Danaher | 152.10 Bn | 147.75 Bn | 3.61 Bn | 7.27 Bn |
| 3 | Natera | 48.48 Bn | 47.38 Bn | 486.15 Mn | 12.21 Mn |
| 4 | Agilent Technologies | 44.35 Bn | 42.55 Bn | 990.00 Mn | -144.00 Mn |
| 5 | Iqvia Holdings | 43.68 Bn | 41.60 Bn | 1.44 Bn | -214.00 Mn |
| 6 | Idexx Laboratories | 43.02 Bn | 42.83 Bn | 779.09 Mn | -325.19 Mn |
| 7 | Illumina | 34.39 Bn | 33.22 Bn | 770.00 Mn | -129.00 Mn |
| 8 | Mettler Toledo International | 28.29 Bn | 28.24 Bn | 650.22 Mn | -317.75 Mn |
| 9 | Labcorp Holdings | 27.51 Bn | 27.37 Bn | 1.11 Bn | -919.90 Mn |
| 10 | Inotiv | 348,881.46 | -14.83 Mn | 111.99 Mn | 5.89 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.89 Mn |
| Mar 31, 2026 | 5.89 Mn |
| Dec 31, 2025 | 1.54 Mn |
| Dec 31, 2025 | 1.54 Mn |
| Sep 30, 2025 | 1.62 Mn |
| Sep 30, 2025 | 1.62 Mn |
| Jun 30, 2025 | -3.41 Mn |
| Jun 30, 2025 | -3.41 Mn |
| Mar 31, 2025 | -632,000.00 |
| Mar 31, 2025 | -632,000.00 |
| Dec 31, 2024 | 26.13 Mn |
| Dec 31, 2024 | 26.13 Mn |
| Sep 30, 2024 | 14.56 Mn |
| Sep 30, 2024 | 14.56 Mn |
| Jun 30, 2024 | -795,000.00 |
| Jun 30, 2024 | -795,000.00 |
| Mar 31, 2024 | -1.17 Mn |
| Mar 31, 2024 | -1.17 Mn |
| Dec 31, 2023 | -2.92 Mn |
| Dec 31, 2023 | -2.92 Mn |